Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRESY
4601
Cresud
CRESY
$767M
| $41.6K | ﹤0.01% |
3,899
| – | – |
|
4602
Invesco BuyBack Achievers ETF
PKW
$1.77B
| $41.5K | ﹤0.01% |
336
| – | – |
|
4603
Noodles & Co
NDLS
$96M
| $41.5K | ﹤0.01% |
7,271
| – | – |
|
|
SLN
4604
Silence Therapeutics
SLN
$729M
| $40.8K | ﹤0.01% |
7,035
+181
| +3% | +$776 |
|
|
ABX
4605
Abacus Global Management
ABX
$913M
| $40.8K | ﹤0.01% |
7,935
-34,596
| -81% | -$256K |
|
4606
Telecom Argentina
TEO
$6.16B
| $39.7K | ﹤0.01% |
4,500
| – | – |
|
4607
Mastech Digital
MHH
$92.7M
| $39.6K | ﹤0.01% |
5,520
-81
| -1% | -$609 |
|
4608
iShares Cybersecurity and Tech ETF
IHAK
$1.12B
| $39.4K | ﹤0.01% |
741
-1,200
| -62% | -$59.7K |
|
4609
Alto Ingredients
ALTO
$328M
| $39.4K | ﹤0.01% |
34,253
-2,381
| -6% | -$2.28K |
|
4610
Global X Data Center & Digital Infrastructure ETF
DTCR
$2.12B
| $39.1K | ﹤0.01% |
2,100
| – | – |
|
|
MESO
4611
Mesoblast
MESO
$2.16B
| $38.9K | ﹤0.01% |
3,571
+1,014
| +40% | +$11.4K |
|
4612
American Well
AMWL
$231M
| $38.7K | ﹤0.01% |
4,348
| – | – |
|
4613
CALL
Virgin Galactic
SPCE
$489M
| $38.2K | ﹤0.01% |
+14,000
| New | +$42.9K |
|
4614
Chunghwa Telecom
CHT
$32.8B
| $38.1K | ﹤0.01% |
+818
| New | +$34.9K |
|
4615
InterContinental Hotels
IHG
$23B
| $38.1K | ﹤0.01% |
+330
| New | +$37K |
|
4616
Innovator US Equity Ultra Buffer ETF April
UAPR
$159M
| $38.1K | ﹤0.01% |
1,216
-4,040
| -77% | -$122K |
|
4617
Caesarstone
CSTE
$88.2M
| $37.5K | ﹤0.01% |
19,038
-17,819
| -48% | -$40.3K |
|
4618
SmartRent
SMRT
$261M
| $37.4K | ﹤0.01% |
37,766
-145,480
| -79% | -$130K |
|
|
IRBT
4619
DELISTED
iRobot
IRBT
| $37.3K | ﹤0.01% |
11,925
-34,396
| -74% | -$95.1K |
|
4620
HUTCHMED
HCM
$2.18B
| $36.8K | ﹤0.01% |
2,442
-4,067
| -62% | -$59.4K |
|
|
CLYM
4621
Climb Bio
CLYM
$778M
| $36.4K | ﹤0.01% |
29,377
-29,353
| -50% | -$36.5K |
|
|
URG
4622
Ur-Energy
URG
$564M
| $36.3K | ﹤0.01% |
34,582
-369,144
| -91% | -$295K |
|
4623
Culp Inc
CULP
$42.7M
| $36.3K | ﹤0.01% |
9,228
| – | – |
|
|
AUTL
4624
Autolus Therapeutics
AUTL
$551M
| $36K | ﹤0.01% |
15,800
+732
| +5% | +$1.21K |
|
4625
Exagen
XGN
$161M
| $35.9K | ﹤0.01% |
5,145
| – | – |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.